A carregar...
Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate
BACKGROUND: High-dose methotrexate (HDMTX) is used in the treatment of certain malignancies, including leptomeningeal metastases, systemic non-Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. High circulating levels of methotrexate can cause severe myelosuppression. The present stud...
Na minha lista:
| Publicado no: | J Pharm Health Care Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782285/ https://ncbi.nlm.nih.gov/pubmed/26958349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-016-0042-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|